Preclinical Assessment of an Anti-EpCAM Immunotoxin:

11

Transcript of Preclinical Assessment of an Anti-EpCAM Immunotoxin:

Page 1: Preclinical Assessment of an Anti-EpCAM Immunotoxin:
Page 2: Preclinical Assessment of an Anti-EpCAM Immunotoxin:
Page 3: Preclinical Assessment of an Anti-EpCAM Immunotoxin:
Page 4: Preclinical Assessment of an Anti-EpCAM Immunotoxin:
Page 5: Preclinical Assessment of an Anti-EpCAM Immunotoxin:
Page 6: Preclinical Assessment of an Anti-EpCAM Immunotoxin:
Page 7: Preclinical Assessment of an Anti-EpCAM Immunotoxin:
Page 8: Preclinical Assessment of an Anti-EpCAM Immunotoxin:
Page 9: Preclinical Assessment of an Anti-EpCAM Immunotoxin:
Page 10: Preclinical Assessment of an Anti-EpCAM Immunotoxin:
Page 11: Preclinical Assessment of an Anti-EpCAM Immunotoxin:

Preclinical research in drug development - journal.emwa.orgjournal.emwa.org/preclinical-studies/preclinical-research-in-drug... · choice of appropriate preclinical models is of utmost

Preclinical research in drug development - journal.emwa.orgjournal.emwa.org/preclinical-studies/preclinical-research-in-drug... · choice of appropriate preclinical models is of utmost

A better immunotoxin against cancer

A better immunotoxin against cancer

1 | Preclinical Programs November 2008 Acorda Therapeutics: Preclinical Pipeline March 6, 2009.

1 | Preclinical Programs November 2008 Acorda Therapeutics: Preclinical Pipeline March 6, 2009.

Gene Knockdown by EpCAM Aptamer siRNA Chimeras … · Large Molecule Therapeutics Gene Knockdown by EpCAM Aptamer–siRNA Chimeras Suppresses Epithelial Breast Cancers and Their Tumor-Initiating

Gene Knockdown by EpCAM Aptamer siRNA Chimeras … · Large Molecule Therapeutics Gene Knockdown by EpCAM Aptamer–siRNA Chimeras Suppresses Epithelial Breast Cancers and Their Tumor-Initiating

EpCAM CD73 - boris.unibe.ch

EpCAM CD73 - boris.unibe.ch

Preclinical trials

Preclinical trials

Preclinical proof of concept and other preclinical issues · Preclinical proof of concept and other preclinical issues . Jennifer Jacobs,Stowaway Jennifer is a New York based artist

Preclinical proof of concept and other preclinical issues · Preclinical proof of concept and other preclinical issues . Jennifer Jacobs,Stowaway Jennifer is a New York based artist

Immunotoxin-mediated Inhibition of Chronic Lymphocytic Leukemia ...

Immunotoxin-mediated Inhibition of Chronic Lymphocytic Leukemia ...

Improving Preclinical to Clinical Translation in Alzheimer ... an… · PTC: Building a Preclinical Testing Pipeline. PTC = Preclinical Testing Core PTC: Building a Preclinical Testing

Improving Preclinical to Clinical Translation in Alzheimer ... an… · PTC: Building a Preclinical Testing Pipeline. PTC = Preclinical Testing Core PTC: Building a Preclinical Testing

Production of unique immunotoxin cancer …Production of unique immunotoxin cancer therapeutics in algal chloroplasts Miller Trana,b, Christina Vana,b, Daniel J. Barreraa,b, Pär L.

Production of unique immunotoxin cancer …Production of unique immunotoxin cancer therapeutics in algal chloroplasts Miller Trana,b, Christina Vana,b, Daniel J. Barreraa,b, Pär L.

Increasing the anti-tumor effect of an EpCAM-targeting ... · Increasing the anti-tumor effect of an EpCAM-targeting fusion toxin by facile click PEGylation Manuel Simon1,2, Nikolas

Increasing the anti-tumor effect of an EpCAM-targeting ... · Increasing the anti-tumor effect of an EpCAM-targeting fusion toxin by facile click PEGylation Manuel Simon1,2, Nikolas

Recombinant immunotoxin engineered for low …Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes Wenhai Liu1,

Recombinant immunotoxin engineered for low …Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes Wenhai Liu1,

CRITERIA FOR PRECLINICAL ALZHEIMER’S DISEASE · PDF fileCRITERIA FOR PRECLINICAL ALZHEIMER’S DISEASE – June 2, 2010 Preclinical Alzheimer’s Disease Workgroup Reisa Sperling,

CRITERIA FOR PRECLINICAL ALZHEIMER’S DISEASE · PDF fileCRITERIA FOR PRECLINICAL ALZHEIMER’S DISEASE – June 2, 2010 Preclinical Alzheimer’s Disease Workgroup Reisa Sperling,

Innovating Novel Immunotoxin Antibody Assets ...

Innovating Novel Immunotoxin Antibody Assets ...

EpCAM/CD3-Bispecific T-cell Engaging Antibody …clincancerres.aacrjournals.org/content/clincanres/18/2/...Cancer Therapy: Preclinical EpCAM/CD3-Bispecific T-cell Engaging Antibody

EpCAM/CD3-Bispecific T-cell Engaging Antibody …clincancerres.aacrjournals.org/content/clincanres/18/2/...Cancer Therapy: Preclinical EpCAM/CD3-Bispecific T-cell Engaging Antibody

Preclinical – Animal Study

Preclinical – Animal Study

Cell and Gene Therapy Catapult preclinical database · Cell and Gene Therapy Catapult preclinical database The UK Preclinical Database covers preclinical research activity concerning

Cell and Gene Therapy Catapult preclinical database · Cell and Gene Therapy Catapult preclinical database The UK Preclinical Database covers preclinical research activity concerning

SMA CK-pan EpCAM - Nordic BioSiteSMA CK-pan EpCAM Fig. 1: Liver Fig. 2: Gastrointestinal stromal tumor (GIST) Anti-SMA, clone BS66, BSH-7459. Tissue sections of liver (Fig. 1) and

SMA CK-pan EpCAM - Nordic BioSiteSMA CK-pan EpCAM Fig. 1: Liver Fig. 2: Gastrointestinal stromal tumor (GIST) Anti-SMA, clone BS66, BSH-7459. Tissue sections of liver (Fig. 1) and

Preclinical – Animal Study - Akademik Ciamik 2010… · PPT file · Web view · 2012-11-042012-11-04 · Preclinical study/preclinical trial. Preclinical trial - a laboratory

Preclinical – Animal Study - Akademik Ciamik 2010… · PPT file · Web view · 2012-11-042012-11-04 · Preclinical study/preclinical trial. Preclinical trial - a laboratory

C Primate Antibody Response Immunotoxin: Serological Computer

C Primate Antibody Response Immunotoxin: Serological Computer